Innoviva Strategic Opportunities Llc Net Worth - Insider Trades and Bio as of May 16, 2026

Innoviva Strategic Opportunities LLC's Net Worth

Estimate Recalculated May 16, 2026 06:36AM EST

Who is Innoviva Strategic Opportunities LLC

Innoviva Strategic Opportunities LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Armata Pharmaceuticals, Inc., and Entasis Therapeutics Holdings Inc..

SEC CIK

Innoviva Strategic Opportunities LLC's CIK is 0001842875

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Armata Pharmaceuticals, Inc.

Investor

Updated Jan 12, 2023

View Quote Details


Form 4	—	19.74M	$1.52	$30.00M	Jan 12, 2023	19.74M	Purchase	—	Jan 10
Form 4	39.38%	5.39M	$5.00	$26.93M	Apr 01, 2022	44.44M	Purchase	—	Mar 31
Form 4	73.61%	5.42M	$5.00	$27.11M	Feb 11, 2022	36.36M	Purchase	—	Feb 09
Form 4	19.70%	1.21M	$3.30	$4.00M	Nov 01, 2021	16.08M	Purchase	—	Oct 29
Form 4	229.45%	8.57M	$3.25	$27.86M	Mar 17, 2021	29.73M	Purchase	—	Mar 17
Form 4	—	3.74M	$3.25	$12.14M	Jan 28, 2021	21.16M	Purchase	—	Jan 26

Showing 6 results

Entasis Therapeutics Holdings Inc.

Investor

Updated Jul 13, 2022


Form 4	192.70%	19.27M	$2.20	$42.40M	Jul 13, 2022	76.62M	Purchase	—	Jul 08 - Jul 11
Form 4	—	—	—	—	Feb 23, 2022	57.35M	Acq/Dis	—	Feb 18
Form 4	168.02%	12.54M	$2.00	$25.08M	Jun 11, 2021	57.35M	Purchase	—	Jun 11
Form 4	—	7.46M	$2.00	$14.92M	May 20, 2021	44.81M	Purchase	—	May 03

Showing 4 results